Spyre Therapeutics, Inc.
Clinical trials sponsored by Spyre Therapeutics, Inc., explained in plain language.
-
New drug hopes to ease joint pain for arthritis sufferers
Disease control Recruiting nowThis study tests a new medicine called SPY002-072 in adults with moderate-to-severe rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. About 285 participants will receive either the drug or a placebo to see if it reduces joint swelling and pain. The goal is to…
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New antibody combo trial aims to calm severe colitis without daily pills
Disease control Recruiting nowThis study tests whether long-acting antibodies, given alone or together, can safely reduce inflammation and improve symptoms in adults with moderate-to-severe ulcerative colitis. About 645 participants will receive the treatment through an IV infusion followed by regular shots. …
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC